Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Potential antipsychotic agents disclosed by Pharmacia & Upjohn

Oct. 11, 1996

Dopamine D3 ligands from Pharmacia & Upjohn

Oct. 11, 1996

New dopamine receptor ligands reported by Neurogen

Oct. 11, 1996

Suntory reports agents for CNS and cerebrovascular disorders

Oct. 11, 1996

Hypnotic agent in the Fujisawa pipeline

Oct. 11, 1996

U.S. approval for anesthetic/analgesic agent

Oct. 11, 1996

Ciba-Geigy reports on further NK1 antagonists

Oct. 11, 1996

New analgesic drugs presented at 8th World Congress on Pain

Oct. 11, 1996

Calpain inhibitors from Fujirebio

Oct. 4, 1996

Astra NOS inhibitors as neuroprotectants

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...